Literature DB >> 24740562

MDM2 SNP309 and risk of cervical cancer.

Stian Knappskog1, Per Eystein Lønning.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24740562     DOI： 10.1007/s13277-014-1910-4

Source DB:  PubMed          Journal:  Tumour Biol        ISSN： 1010-4283


× No keyword cloud information.
  7 in total

1.  Differential effects of MDM2 SNP309 polymorphism on breast cancer risk along with race: a meta-analysis.

Authors:  Konstantinos P Economopoulos; Theodoros N Sergentanis
Journal:  Breast Cancer Res Treat       Date:  2009-07-10       Impact factor: 4.872

2.  SNP285C modulates oestrogen receptor/Sp1 binding to the MDM2 promoter and reduces the risk of endometrial but not prostatic cancer.

Authors:  Stian Knappskog; Jone Trovik; Janusz Marcickiewicz; Solveig Tingulstad; Annetine C Staff; Pål Romundstad; Kristian Hveem; Lars Vatten; Helga B Salvesen; Per E Lønning
Journal:  Eur J Cancer       Date:  2011-11-24       Impact factor: 9.162

3.  The MDM2 promoter SNP285C/309G haplotype diminishes Sp1 transcription factor binding and reduces risk for breast and ovarian cancer in Caucasians.

Authors:  Stian Knappskog; Merete Bjørnslett; Line M Myklebust; Petra E A Huijts; Maaike P Vreeswijk; Hege Edvardsen; Yongli Guo; Xuemei Zhang; Ming Yang; Sanna K Ylisaukko-Oja; Pia Alhopuro; Johanna Arola; Rob A E M Tollenaar; Christi J van Asperen; Caroline Seynaeve; Vidar Staalesen; Ranjan Chrisanthar; Erik Løkkevik; Helga B Salvesen; D Gareth Evans; William G Newman; Dongxin Lin; Lauri A Aaltonen; Anne-Lise Børresen-Dale; Grethe S Tell; Camilla Stoltenberg; Pål Romundstad; Kristian Hveem; Johan R Lillehaug; Lars Vatten; Peter Devilee; Anne Dørum; Per E Lønning
Journal:  Cancer Cell       Date:  2011-02-15       Impact factor: 31.743

4.  A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans.

Authors:  Gareth L Bond; Wenwei Hu; Elisabeth E Bond; Harlan Robins; Stuart G Lutzker; Nicoleta C Arva; Jill Bargonetti; Frank Bartel; Helge Taubert; Peter Wuerl; Kenan Onel; Linwah Yip; Shih-Jen Hwang; Louise C Strong; Guillermina Lozano; Arnold J Levine
Journal:  Cell       Date:  2004-11-24       Impact factor: 41.582

5.  MDM2 SNP309 variation increases cervical cancer risk among Asians.

Authors:  Xianlu Zhuo; Jie Ren; Dairong Li; Yongzhong Wu; Qi Zhou
Journal:  Tumour Biol       Date:  2014-02-15

6.  MDM2 promoter polymorphism SNP309 contributes to tumor susceptibility: evidence from 21 case-control studies.

Authors:  Zhibin Hu; Guangfu Jin; Lu Wang; Feng Chen; Xinru Wang; Hongbing Shen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-12       Impact factor: 4.254

7.  MDM2 promoter SNP285 and SNP309; phylogeny and impact on cancer risk.

Authors:  Stian Knappskog; Per E Lønning
Journal:  Oncotarget       Date:  2011-03
  7 in total
  2 in total

1.  Association of Murine Double Minute 2 polymorphisms with gastric cancer: A systematic review with meta-analysis.

Authors:  Mafalda Timóteo; Ana Tavares; Sara Cruz; Carla Campos; Rui Medeiros; Hugo Sousa
Journal:  Biomed Rep       Date:  2021-06-17

2.  Murine Double-Minute 2 Homolog Single Nucleotide Polymorphisms 285 and 309 in Cervical Carcinogenesis.

Authors:  Andrzej Roszak; Matthew Misztal; Anna Sowińska; Pawel P Jagodziński
Journal:  Mol Diagn Ther       Date:  2015-08       Impact factor: 4.074
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.